New EudraVigilance System To Usher In Simplified Reporting of ADRs From Nov. 22
Executive Summary
The European Medicines Agency is asking drug companies and EU national competent authorities to prepare for the late November launch of the new EU pharmacovigilance database, which will have enhanced functionalities for reporting and analysing suspected adverse reactions.